A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates-Reference-Cited by-同舟云学术

A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates

Published:2021-05-27 Issue:10 Volume:29 Page:1118-1127
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Kina Shinichiro¹²,Kawabata-Iwakawa Reika³,Miyamoto Sho¹,Arasaki Akira¹,Sunakawa Hajime¹,Kinjo Takao⁴

Affiliation:

1. Department of Oral and Maxillofacial Functional Rehabilitation, Graduate School of Medicine, University of the Ryukyus, Nakagami-gun, Japan

2. Department of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan

3. Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research, Maebashi, Japan

4. Department of Basic Laboratory Sciences, Division of Morphological Pathology, School of Health Sciences, University of the Ryukyus, Nakagami-gun, Japan

Funder

JSPS KAKENHI

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2021.1929256

Reference54 articles.

1. Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers

2. Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance

3. Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth